Beta2-agonists and paresthesias in multiple sclerosis.

Axelrod S, Bielory L. Beta2-agonists and paresthesias in multiple sclerosis. Ann Allergy Asthma Immunol. 2007 Jan; 98(1):100.

View in: PubMed

subject areas

Adrenergic beta-Agonists
Albuterol
Amantadine
Analgesics, Non-Narcotic
Androstadienes
Aromatase Inhibitors
Asthma
Bronchodilator Agents
Drug Therapy, Combination
Female
Fluticasone
Food Hypersensitivity
Humans
Indans
Interferons
Latex Hypersensitivity
Mandelic Acids
Middle Aged
Multiple Sclerosis
Nebulizers and Vaporizers
Nitriles
Nootropic Agents
Parasympatholytics
Paresthesia
Piperidines
Respiratory Function Tests
Salmeterol Xinafoate
Thyroxine
Triazoles

authors with profiles

Leonard Bielory

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement